European pharmaceutical companies are calling on governments to increase investment in medicines, accelerate clinical trials and strengthen intellectual-property protections as the industry faces...
ByBenson T. DanielSeptember 22, 2026GSK has secured two regulatory milestones that could strengthen its pharmaceutical pipeline and support future growth. Japan has approved bepirovirsen, GSK’s treatment for...
ByBenedict LanahAugust 24, 2026Excepteur sint occaecat cupidatat non proident